
### [MONDO:0019737](http://purl.obolibrary.org/obo/MONDO_0019737)
**Label:** thrombotic microangiopathy

**Subclasses:** [MONDO:0019725](http://purl.obolibrary.org/obo/MONDO_0019725) (pediatric systemic lupus erythematosus), [MONDO:0012350](http://purl.obolibrary.org/obo/MONDO_0012350) (complement factor H deficiency), [MONDO:0019536](http://purl.obolibrary.org/obo/MONDO_0019536) (Typical hemolytic-uremic syndrome), [MONDO:0014005](http://purl.obolibrary.org/obo/MONDO_0014005) (immunoglobulin-mediated membranoproliferative glomerulonephritis), [MONDO:0013041](http://purl.obolibrary.org/obo/MONDO_0013041) (atypical hemolytic-uremic syndrome with i factor anomaly), [MONDO:0010122](http://purl.obolibrary.org/obo/MONDO_0010122) (congenital thrombotic thrombocytopenic purpura), [MONDO:0018896](http://purl.obolibrary.org/obo/MONDO_0018896) (thrombotic thrombocytopenic purpura), [MONDO:0018159](http://purl.obolibrary.org/obo/MONDO_0018159) (atypical hemolytic-uremic syndrome with DGKE deficiency), [MONDO:0013042](http://purl.obolibrary.org/obo/MONDO_0013042) (atypical hemolytic-uremic syndrome with b factor anomaly), [MONDO:0019740](http://purl.obolibrary.org/obo/MONDO_0019740) (acquired thrombotic thrombocytopenic purpura), [MONDO:0013043](http://purl.obolibrary.org/obo/MONDO_0013043) (atypical hemolytic-uremic syndrome with C3 anomaly), [MONDO:0016244](http://purl.obolibrary.org/obo/MONDO_0016244) (atypical hemolytic-uremic syndrome), [MONDO:0013044](http://purl.obolibrary.org/obo/MONDO_0013044) (atypical hemolytic-uremic syndrome with thrombomodulin anomaly), [MONDO:0009335](http://purl.obolibrary.org/obo/MONDO_0009335) (hemolytic uremic syndrome, atypical, susceptibility to, 1), [MONDO:0013040](http://purl.obolibrary.org/obo/MONDO_0013040) (atypical hemolytic-uremic syndrome with MCP/CD46 anomaly), [MONDO:0016061](http://purl.obolibrary.org/obo/MONDO_0016061) (immunodeficiency with factor H anomaly), [MONDO:0009609](http://purl.obolibrary.org/obo/MONDO_0009609) (methylcobalamin deficiency type cblG), [MONDO:0019739](http://purl.obolibrary.org/obo/MONDO_0019739) (atypical hemolytic-uremic syndrome with anti-factor H antibodies), [MONDO:0019738](http://purl.obolibrary.org/obo/MONDO_0019738) (atypical hemolytic-uremic syndrome with H factor anomaly), 

**Mapped go classes:** [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development), [GO:0004143](http://purl.obolibrary.org/obo/GO_0004143) (diacylglycerol kinase activity), [GO:0048639](http://purl.obolibrary.org/obo/GO_0048639) (positive regulation of developmental growth), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0006957](http://purl.obolibrary.org/obo/GO_0006957) (complement activation, alternative pathway), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001798](http://purl.obolibrary.org/obo/GO_0001798) (positive regulation of type IIa hypersensitivity), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0042558](http://purl.obolibrary.org/obo/GO_0042558) (pteridine-containing compound metabolic process), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0003951](http://purl.obolibrary.org/obo/GO_0003951) (NAD+ kinase activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:2000427](http://purl.obolibrary.org/obo/GO_2000427) (positive regulation of apoptotic cell clearance), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0048037](http://purl.obolibrary.org/obo/GO_0048037) (cofactor binding), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0009235](http://purl.obolibrary.org/obo/GO_0009235) (cobalamin metabolic process), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process), [GO:0031715](http://purl.obolibrary.org/obo/GO_0031715) (C5L2 anaphylatoxin chemotactic receptor binding), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0009086](http://purl.obolibrary.org/obo/GO_0009086) (methionine biosynthetic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0008705](http://purl.obolibrary.org/obo/GO_0008705) (methionine synthase activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0010866](http://purl.obolibrary.org/obo/GO_0010866) (regulation of triglyceride biosynthetic process), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0050819](http://purl.obolibrary.org/obo/GO_0050819) (negative regulation of coagulation), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0046834](http://purl.obolibrary.org/obo/GO_0046834) (lipid phosphorylation), [GO:0001970](http://purl.obolibrary.org/obo/GO_0001970) (positive regulation of activation of membrane attack complex), [GO:0045745](http://purl.obolibrary.org/obo/GO_0045745) (positive regulation of G-protein coupled receptor protein signaling pathway), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0043171](http://purl.obolibrary.org/obo/GO_0043171) (peptide catabolic process), [GO:0030449](http://purl.obolibrary.org/obo/GO_0030449) (regulation of complement activation), [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0045919](http://purl.obolibrary.org/obo/GO_0045919) (positive regulation of cytolysis), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0008652](http://purl.obolibrary.org/obo/GO_0008652) (cellular amino acid biosynthetic process), [GO:0007205](http://purl.obolibrary.org/obo/GO_0007205) (protein kinase C-activating G-protein coupled receptor signaling pathway), [GO:0006479](http://purl.obolibrary.org/obo/GO_0006479) (protein methylation), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:0061304](http://purl.obolibrary.org/obo/GO_0061304) (retinal blood vessel morphogenesis), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0001851](http://purl.obolibrary.org/obo/GO_0001851) (complement component C3b binding), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050667](http://purl.obolibrary.org/obo/GO_0050667) (homocysteine metabolic process), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.56%
- [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity) 53.23%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 51.61%
- [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding) 51.61%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 51.61%
- [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding) 51.61%
- [GO:0042084](http://purl.obolibrary.org/obo/GO_0042084) (5-methyltetrahydrofolate-dependent methyltransferase activity) 51.61%
- [GO:0031715](http://purl.obolibrary.org/obo/GO_0031715) (C5L2 anaphylatoxin chemotactic receptor binding) 51.61%
- [GO:0031714](http://purl.obolibrary.org/obo/GO_0031714) (C5a anaphylatoxin chemotactic receptor binding) 51.61%
- [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding) 51.61%
- [GO:0008705](http://purl.obolibrary.org/obo/GO_0008705) (methionine synthase activity) 51.61%
- [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding) 51.61%
- [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding) 51.61%
- [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding) 51.61%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 51.61%


